Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.

Alcoholism, or alcohol use disorder, is a major public health concern that is a considerable risk factor for morbidity and disability; therefore, effective treatments are urgently needed. Here, we demonstrated that the glucocorticoid receptor (GR) antagonist mifepristone reduces alcohol intake in alcohol-dependent rats but not in nondependent animals. Both systemic delivery and direct administration into the central nucleus of the amygdala, a critical stress-related brain region, were sufficient to reduce alcohol consumption in dependent animals. We also tested the use of mifepristone in 56 alcohol-dependent human subjects as part of a double-blind clinical and laboratory-based study. Relative to placebo, individuals who received mifepristone (600 mg daily taken orally for 1 week) exhibited a substantial reduction in alcohol-cued craving in the laboratory, and naturalistic measures revealed reduced alcohol consumption during the 1-week treatment phase and 1-week post-treatment phase in mifepristone-treated individuals. Mifepristone was well tolerated and improved liver-function markers. Together, these results support further exploration of GR antagonism via mifepristone as a therapeutic strategy for alcoholism.

[1]  W. Sommer,et al.  Postdependent state in rats as a model for medication development in alcoholism , 2015, Addiction biology.

[2]  A. Roberts,et al.  Operant alcohol self-administration in dependent rats: focus on the vapor model. , 2014, Alcohol.

[3]  A. R. Reynolds,et al.  Mifepristone pretreatment reduces ethanol withdrawal severity in vivo. , 2013, Alcoholism, clinical and experimental research.

[4]  G. Koob.  Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. , 2013, Current topics in behavioral neurosciences.

[5]  G. Koob,et al.  Neuroscience and Biobehavioral Reviews Alcohol Dependence as a Chronic Pain Disorder , 2022 .

[6]  G. Koob,et al.  Corticosteroid-Dependent Plasticity Mediates Compulsive Alcohol Drinking in Rats , 2012, The Journal of Neuroscience.

[7]  S. Bartlett,et al.  Mifepristone in the Central Nucleus of the Amygdala Reduces Yohimbine Stress-Induced Reinstatement of Ethanol-Seeking , 2012, Neuropsychopharmacology.

[8]  G. Koob,et al.  Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol‐dependent rats , 2012, Addiction biology.

[9]  B. Mason,et al.  A Translational Approach to Novel Medication Development for Protracted Abstinence , 2012 .

[10]  D. Oslin,et al.  Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. , 2011, Journal of studies on alcohol and drugs.

[11]  J. Herman,et al.  Mechanisms of rapid glucocorticoid feedback inhibition of the hypothalamic–pituitary–adrenal axis , 2011, Stress.

[12]  G. Koob,et al.  Neurobiology of dysregulated motivational systems in drug addiction. , 2010, Future neurology.

[13]  L. Parsons,et al.  Corticotropin Releasing Factor–Induced Amygdala Gamma-Aminobutyric Acid Release Plays a Key Role in Alcohol Dependence , 2010, Biological Psychiatry.

[14]  G. Koob,et al.  Operant behavior and alcohol levels in blood and brain of alcohol-dependent rats. , 2009, Alcoholism, clinical and experimental research.

[15]  G. Koob,et al.  Development of pharmacotherapies for drug addiction: a Rosetta Stone approach , 2009, Nature Reviews Drug Discovery.

[16]  G. Wand,et al.  Stress, alcohol and drug interaction: an update of human research , 2009, Addiction biology.

[17]  G. Koob,et al.  Alcohol self‐administration acutely stimulates the hypothalamic‐pituitary‐adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state , 2008, The European journal of neuroscience.

[18]  J. Light,et al.  Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics , 2008, Psychopharmacology.

[19]  G. Koob,et al.  A key role for corticotropin-releasing factor in alcohol dependence , 2007, Trends in Neurosciences.

[20]  G. Koob,et al.  Corticotropin-Releasing Factor within the Central Nucleus of the Amygdala Mediates Enhanced Ethanol Self-Administration in Withdrawn, Ethanol-Dependent Rats , 2006, The Journal of Neuroscience.

[21]  C. Fahlke,et al.  Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists , 2005, Psychopharmacology.

[22]  M. Olive,et al.  The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions , 2004, Psychoneuroendocrinology.

[23]  C. Cook.  Glucocorticoid feedback increases the sensitivity of the limbic system to stress , 2002, Physiology & Behavior.

[24]  M. Litt,et al.  Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. , 1997, Journal of abnormal psychology.

[25]  G. Koob,et al.  Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. , 1996, Alcoholism, clinical and experimental research.

[26]  G. Koob,et al.  Decreased brain reward produced by ethanol withdrawal. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Dobs,et al.  Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. , 1991, The Journal of clinical endocrinology and metabolism.

[28]  P. Sawchenko.  Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus , 1987, Brain Research.